Patents by Inventor Igor Solodin

Igor Solodin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amphiphilic biguanide derivatives
    Patent number: 5958894
    Abstract: Cationic derivatives of biguanide are provided, which are useful in the preparation of lipid carriers for mediating transfection of mammalian cells in vivo and in vitro.
    Type: Grant
    Filed: April 4, 1997
    Date of Patent: September 28, 1999
    Assignee: Megabios Corporation
    Inventors: Timothy D. Heath, Igor Solodin, Jinkang Wang, Yi-Lin Zhang
  • Amphiphilic derivatives of piperazine
    Patent number: 5776908
    Abstract: Novel, heterocyclic cationic amphiphile and compounds thereof are prepared that are degraded in vivo. Liposomes are produced from the cations that are used as carriers for delivering macromolecules intracellularly and may be targeted to a specific cell type.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: July 7, 1998
    Assignee: Megabios Corp.
    Inventors: Timothy D. Heath, Igor Solodin
  • Amphiphilic imidazolinium derivatives
    Patent number: 5736395
    Abstract: Amphiphiles containing an imidazdinium ring system are provided that are non-toxic to the host mammal. The amphiphiles are used to produce liposomes useful as carriers for delivering macromolecules intracellularly.
    Type: Grant
    Filed: May 19, 1997
    Date of Patent: April 7, 1998
    Assignee: Megabios Corporation
    Inventors: Timothy D. Heath, Igor Solodin
  • Amphiphilic nitrogen containing imidazolinium derivative compounds and uses
    Patent number: 5705655
    Abstract: Amphiphiles containing an imidazdinium ring system are provided that are non-toxic to the host mammal. The amphiphiles are used to produce liposomes useful as carriers for delivering macromolecules intracellularly.
    Type: Grant
    Filed: May 24, 1994
    Date of Patent: January 6, 1998
    Assignee: Megabios Corporation
    Inventors: Timothy D. Heath, Igor Solodin
  • Amphiphilic derivatives of piperazine
    Patent number: 5665879
    Abstract: Novel, heterocyclic cationic amphiphile and compounds thereof are prepared that are degraded in vivo. Liposomes are produced from the cations that are used as carriers for delivering macromolecules intracellularly and may be targeted to a specific cell type.
    Type: Grant
    Filed: June 7, 1994
    Date of Patent: September 9, 1997
    Assignee: Megabios Corporation
    Inventors: Timothy D. Heath, Igor Solodin